Skip to main content
SHRYDUS INDUSTRIES LIMITED logo

SHRYDUS INDUSTRIES LIMITED — Investor Relations & Filings

Ticker · 511493 ISIN · INE488C01015 BSE.NS Wholesale and retail trade
Open in API
Filings indexed 333 across all filing types
Latest filing 2023-07-18 Regulatory Filings
Country IN India
Listing BSE.NS 511493

About SHRYDUS INDUSTRIES LIMITED

https://shrydus.com/

Shrydus Industries Limited is a diversified enterprise focused on the trading and distribution of industrial commodities and consumer goods. The company specializes in the procurement and supply of products across multiple sectors, including chemicals, textiles, and metal components. By integrating strategic sourcing with efficient supply chain management, the company facilitates the movement of raw materials and finished products to various manufacturing and commercial entities. Its operations emphasize quality assurance, market-driven procurement strategies, and the maintenance of a robust logistics network to ensure consistent service delivery. The company aims to provide value-added solutions through comprehensive market analysis and a commitment to operational excellence in the trading domain.

Recent filings

Filing Released Lang Actions
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is an intimation letter addressed to the compliance department of BSE Limited regarding the loss of share certificates. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to reporting share certificate loss and related shareholding information. The content is a regulatory notification about share certificate status, not a financial report, earnings release, or management discussion. It is a formal regulatory filing to comply with stock exchange disclosure requirements. The document length is short (3183 characters), and it is not announcing or attaching a report but providing a regulatory compliance update. Therefore, the appropriate classification is Regulatory Filings (RNS).
2023-07-18 English
Statement of deviation or variation in the use of proceeds of Preferential issue
Capital/Financing Update Classification · 95% confidence The document is a statement submitted to the stock exchange (BSE Limited) regarding the use of proceeds from a Preferential Issue. It confirms that there is no deviation or variation in the use of funds raised compared to the objects stated in the explanatory statement of the related meeting. The document references SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 32, which mandates disclosure of deviations in fund utilization. The content is a compliance disclosure about capital raising and fund usage, not a full financial report or earnings release. It is an update on capital/financing activity, specifically about the use of proceeds from a preferential issue. The document length is short (4238 characters) and it is a formal statement rather than a report or presentation. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2023-07-05 English
Statement of deviation or variation in the use of proceeds of Preferential issue
Capital/Financing Update Classification · 95% confidence The document is a statement regarding the deviation or variation in the use of proceeds from a Preferential Issue, filed pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It confirms that there is no deviation or variation in the use of funds raised as per the objects stated in the explanatory statement to the notice of an Extraordinary General Meeting. The content focuses on compliance and disclosure related to capital raising and fund utilization, specifically for a preferential issue. This type of document is an update on capital/financing activities rather than a full financial report or audit. Therefore, it fits best under the category 'Capital/Financing Update' (CAP). The document length is 4246 characters, which is sufficient to contain substantive information rather than just an announcement. Hence, the classification is CAP with high confidence.
2023-07-05 English
INTIMATION FOR CLOSURE OF TRADING WINDOW
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchange about the closing of the trading window for insiders ahead of the financial results announcement for the quarter ended June 30, 2023. It references SEBI regulations and BSE circulars related to insider trading. The document does not contain any financial data, results, or detailed report content. It is an announcement related to compliance and trading restrictions rather than a financial report or earnings release. Given its short length (1093 characters) and nature as a regulatory notification, it fits best under Regulatory Filings (RNS).
2023-06-30 English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is an intimation letter under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding loss of share certificates and the request for issuance of duplicate share certificates. It includes details of share certificates lost and related KYC update forms. The document is a regulatory compliance notification to the stock exchange and does not contain financial statements, management discussion, or detailed financial data. It is also relatively short (3651 characters) and serves as an official announcement of a corporate action related to share certificates. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-06-14 English
With reference to the above captioned subject, we would like to submit the attached note from Mr. Shrey Premal Parekh, Managing Director of the company
Regulatory Filings Classification · 95% confidence The document is a general update letter addressed to stock exchanges and shareholders. It discusses the company's recent name change, strategic direction into the pharmaceutical manufacturing sector, and ongoing negotiations for acquisition or partnership. The document explicitly states that the disclosure is voluntary and not material information. It does not contain financial statements, detailed financial performance data, or regulatory certifications. The length is about 4015 characters, which is relatively short and more consistent with an announcement or update rather than a full report. There is no indication that this is an annual report, interim report, earnings release, or any detailed financial filing. It is also not a proxy, voting result, or management change announcement. The content fits best as a general regulatory announcement or update to the market and shareholders, which aligns with the Regulatory Filings (RNS) category as a fallback for miscellaneous filings that do not fit other categories.
2023-06-12 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.